MedPath

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.hopkinsmedicine.org/kimmel_cancer_center

Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis

Completed
Conditions
Dermatitis
Breast Cancer
First Posted Date
2009-05-07
Last Posted Date
2019-05-07
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
12
Registration Number
NCT00894712
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

Phase 1
Terminated
Conditions
Head and Neck Cancer
Interventions
First Posted Date
2009-04-16
Last Posted Date
2019-01-09
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
22
Registration Number
NCT00882583
Locations
🇺🇸

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

Phase 2
Terminated
Conditions
Myelodysplastic Syndrome
Interventions
First Posted Date
2009-03-23
Last Posted Date
2018-10-17
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
32
Registration Number
NCT00867308
Locations
🇺🇸

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Early Phase 1
Completed
Conditions
NF2
Acoustic Neuroma
Neurofibromatosis 2
Auditory Tumor
Vestibular Schwannoma
Interventions
First Posted Date
2009-03-17
Last Posted Date
2021-01-12
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
26
Registration Number
NCT00863122
Locations
🇺🇸

House Reserach Institute, Los Angeles, California, United States

🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

and more 4 locations

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Phase 1
Terminated
Conditions
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Myeloproliferative Disorders
Chronic Myelomonocytic Leukemia
Juvenile Myelomonocytic Leukemia
Myelodysplastic Syndrome
Acute Promyelocytic Leukemia
Acute Leukemia
Myelofibrosis
First Posted Date
2009-02-27
Last Posted Date
2018-02-15
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
35
Registration Number
NCT00852709
Locations
🇺🇸

University of Colorado Health Sciences Center and The Children's Hospital, Aurora, Colorado, United States

🇺🇸

Pediatrix Hematology/Oncology University of Florida College of Medicine, Gainesville, Florida, United States

🇺🇸

M.D. Anderson Comprehensive Cancer Center, Houston, Texas, United States

and more 4 locations

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: allogeneic GM-CSF-secreting breast cancer vaccine
Biological: trastuzumab
Other: flow cytometry
Other: immunoenzyme technique
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis
Other: pharmacological study
Procedure: biopsy
First Posted Date
2009-02-19
Last Posted Date
2018-09-26
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
20
Registration Number
NCT00847171
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Phase 1
Completed
Conditions
Pancreatic Cancer
Interventions
Biological: Pancreatic Cancer Vaccine
First Posted Date
2009-02-04
Last Posted Date
2020-02-24
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
30
Registration Number
NCT00836407
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Cytokine Expression During Radiation for Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Radiation: Radiation therapy
First Posted Date
2009-02-04
Last Posted Date
2020-10-08
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
82
Registration Number
NCT00836186
Locations
🇺🇸

The Johns Hopkins University School of Medicne, Baltimore, Maryland, United States

🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Phase 2
Terminated
Conditions
Non-Hodgkin's Lymphoma
Interventions
First Posted Date
2008-12-17
Last Posted Date
2018-09-25
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
27
Registration Number
NCT00809341
Locations
🇺🇸

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

Phase 2
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Radiation: hypofractionation
First Posted Date
2008-12-17
Last Posted Date
2024-04-17
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
188
Registration Number
NCT00809991
Locations
🇺🇸

The Johns Hopkins University School of Medicne, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath